Mumps virus inhibits migration of primary human macrophages toward a chemokine gradient through a TNF-alpha dependent mechanism  by Briggs, Caitlin M. et al.
Virology 433 (2012) 245–252Contents lists available at SciVerse ScienceDirectVirology0042-68
http://d
n Corr
Forest S
1064, U
E-mjournal homepage: www.elsevier.com/locate/yviroMumps virus inhibits migration of primary human macrophages toward
a chemokine gradient through a TNF-alpha dependent mechanismCaitlin M. Briggs, Anne E. Mayer, Grifﬁth D. Parks n
Department of Microbiology and Immunology, Wake Forest School of Medicine, Winston-Salem, NC 27157-1064, USAa r t i c l e i n f o
Article history:
Received 21 May 2012
Returned to author for revisions
22 June 2012
Accepted 10 August 2012
Available online 28 August 2012
Keywords:
Paramyxovirus
Macrophage22/$ - see front matter & 2012 Elsevier Inc. A
x.doi.org/10.1016/j.virol.2012.08.017
espondence to: Department of Microbiolo
chool of Medicine, Medical Center Boulevard
SA. Fax: þ1 336 716 9928.
ail address: gparks@wfubmc.edu (G.D. Parks)a b s t r a c t
Macrophages are an important cell type for regulation of immunity, and can play key roles in virus
pathogenesis. Here we address the effect of infection of primary human macrophages with the related
paramyxoviruses Parainﬂuenza virus 5 (PIV5) and Mumps virus (MuV). Monocyte-derived macro-
phages infected with PIV5 or MuV showed very little cytopathic effect, but were found to be defective
in migration toward a gradient of chemokines such as macrophage colony stimulating factor (MCSF)
and vascular endothelial growth factor (VEGF). For MuV infection, the inhibition of migration required
live virus infection, but was not caused by a loss of chemokine receptors on the surface of infected cells.
MuV-mediated inhibition of macrophage chemotaxis was through a soluble factor released from
infected cells. MuV infection enhanced secretion of TNF-a, but not macrophage inhibitory factor (MIF).
Antibody inhibition and add-back experiments demonstrated that TNF-a was both necessary and
sufﬁcient for MuV-mediate chemotaxis inhibition.
& 2012 Elsevier Inc. All rights reserved.Introduction
Macrophages are an important cell type that plays a crucial
role in modulating both innate and adaptive immune responses to
viral infection (reviewed in Mosser and Edwards, 2008; Murray
and Wynn, 2011). Upon detection of a virus, macrophages are
recruited to the site of infection through the release of chemo-
kines by epithelial cells and innate immune cells. Once localized
to the site of infection, macrophages are able to phagocytose
viruses or infected cell debris, process and present antigen, and
migrate to lymph nodes to activate T cells and stimulate the
adaptive immune response (Lehtonen et al., 2007). However, a
ﬁne regulation of macrophage trafﬁcking is needed to avoid
chronic inﬂammation, impaired tissue healing, and recurrent
infection in a host (Frascaroli et al., 2009). Therefore, it is
important that macrophages are readily able to move to the site
of an infection, be retained in those tissues to combat a pathogen,
and then egress out of the tissues to avoid overt damaging the
host. In this study, we address the question of the impact of two
related paramyxoviruses, Mumps Virus (MuV) and Parainﬂuenza
virus 5 (PIV5) on macrophage migration.
Macrophages are specialized lymphocytes whose functions
include a number of important aspects in innate and adaptivell rights reserved.
gy and Immunology, Wake
, Winston-Salem, NC 27157-
.responses to virus infection (Lehtonen et al., 2007). In some cases
such as with inﬂuenza virus, the ability of macrophages to
respond to virus has been shown to be crucial in determining
the outcome of respiratory tract infection (Kim et al., 2008;
Wijburg et al., 1997). Macrophages have been shown to express
high levels of the co-stimulatory molecules CD80 and CD86 on
their cell surface, a property which allows these cells to present
antigen to lymphocytes (Mosser and Edwards, 2008; Murray and
Wynn, 2011; Wijburg et al., 1997). In addition, macrophages
respond to pathogens by secreting pro-inﬂammatory cytokines
such as IL-6, IFN-b, RANTES, and TNF-a (Assuncao-Miranda et al.,
2010; Mosser and Edwards, 2008), and these cytokines are able to
act in both an autocrine and paracrine fashion to stimulate
additional innate and adaptive immune responses. Here, we
demonstrate that MuV infection of primary human macrophages
induces the production of TNF-a, and this MuV-mediated produc-
tion of TNF-a has a profound effect on macrophage function.
PIV5 is a prototype virus which has served as a model
parainﬂuenza for the study of paramyxoviruses in general and
the Rubulavirus family in particular (reviewed in Lamb and Parks,
2007). PIV5 is closely related to two other Rubulaviruses: MuV
and Human Parainﬂuenza virus type 2. MuV is the causative agent
of mumps in humans, a viral infection of children and adolescents
characterized by swelling of the parotid glands (Hviid et al.,
2008). In addition, MuV infection often results in secondary
complications, including aseptic meningitis, deafness, sterility in
males, and can be highly neurotropic (Rubin and Afzal, 2011).
Although the introduction of the MuV vaccine has been successful
C.M. Briggs et al. / Virology 433 (2012) 245–252246in reducing infection in the general population, there have been
increasing numbers of MuV infections reported in vaccinated
populations. Available data support waning immunity as the
mechanism behind these outbreaks, as opposed to immune
escape (Rubin et al., 2011).
Given that macrophages rely heavily on chemotaxis to perform
their functions for both innate and adaptive immune responses,
we have tested the effects of PIV5 and MuV infection on macro-
phage motility. Using primary human macrophages, we demon-
strate that infections with both PIV5 and MuV show minimal
cytopathic effect (CPE), but infected macrophages have a signiﬁ-
cantly reduced ability to migrate toward chemoattractants. For
MuV, TNF-a secreted during viral infection was found to be both
necessary and sufﬁcient to account for the defect in macrophage
migration. Our results have implications for potential treatment
of viral infections that are capable of exploiting normal host cell
responses for their own beneﬁt.Results
PIV5 infection of human macrophages restricts migration toward
chemokines
To determine the outcome of infection of primary human
macrophages with PIV5, CD14þ monocytes were isolated from
human PBMCs and cultured for six days in the presence of MCSF.PIV5-GFPMock
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Fig. 1. PIV5 infected primary human macrophages are inhibited in chemotaxis. (A and B
infected with WT PIV5-GFP at an moi of 10. At 24 h pi, cells were examined for GFP
production. Primary human macrophages were mock infected or infected at high moi
assayed by ELISA for production of IL-6. Results are the mean values (with bars ind
Chemotaxis. Macrophages were mock infected (gray bars) or infected with WT PIV5-G
toward the chemokine MCP-1 or MCSF as described in Materials and methods. Resul
indicating standard deviation) for three samples from a representative donor. Data are
different donors. **po0.005.At that time, 490% of cells were found to be CD14þ , CD11bþ ,
and CD64þ , a characteristic marker proﬁle of monocyte-derived
macrophages (MDMs, Briggs et al., 2011). Macrophages were
mock infected or infected with WT PIV5 that encoded GFP at an
moi of 10 and then examined by microscopy at 24 h pi. As shown
in Fig. 1A, PIV5 was capable of initiating a productive infection of
human macrophages as evidenced by new gene expression.
However, no progeny virus was detected (data not shown).
Importantly, PIV5 infection did not show overt CPE compared to
mock infected macrophages. To conﬁrm the lack of CPE, macro-
phages from three donors were infected with WT PIV5-GFP at an
moi of 10. At 24 h pi, an MTT assay was done to evaluate cell
viability. As shown in Fig. 1B, infected macrophages from all three
donors showed a slight reduction in cell proliferation, similar to
that seen during infections of human epithelial cells in culture
(Manuse and Parks, 2010; Wansley and Parks, 2002) and consis-
tent with the ﬁnding that PIV5 slows the cell cycle (Lin and Lamb,
2000). Thus, in contrast to the dramatic cell death seen with WT
PIV5 infection of human DC (Arimilli et al., 2006), infected
primary human macrophages display little CPE.
We have previously shown that WT PIV5 is a poor inducer of
proinﬂammatory cytokines in human DC and epithelial cells. To
determine if cytokines were induced in infected macrophages,
human MDMs were mock infected or infected with WT PIV5 at an
moi of 10, and levels of IL-6 were assayed by ELISA at days 1, 3,
and 5 pi. As shown in Fig. 1C, PIV5-infected macrophages produced
only low levels of IL-6, in contrast to cells treated with the positive100
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) Infection of primary human macrophages. Macrophages were mock infected or
expression (panel A) or for viability using an MTT assay (panel B). (C) Cytokine
with WT PIV5-GFP or the P/V-CPI- mutant. At the indicated days pi, media were
icating standard deviation) for three samples from a representative donor. (D)
FP at an moi of 10 (solid bars), and 24 h pi cells were used in a migration assay
ts are expressed as the mean number of cells in 10 high power ﬁelds (with bars
representative of the results obtained from multiple experiments with cells from
C.M. Briggs et al. / Virology 433 (2012) 245–252 247control stimulus LPS or infected with the cytokine-inducing PIV5 P/V
mutant (Wansley and Parks, 2002). PIV5 infection also resulted in
minimal increases in MIF and TNF-a (not shown). Thus, cytokine
induction by primary human MDMs infected with PIV5 is similar to
that seen with human epithelial cells.
To determine if macrophage chemotaxis was altered by PIV5
infection, primary human macrophages were infected with WT
PIV5-GFP at an moi of 10. At 24 h pi, cells were collected, plated in
a transwell culture dish, and allowed to undergo chemotaxis for
4 h toward the chemokines MCP-1 or MCSF, or toward PBS as a
negative control. Filters were ﬁxed and stained, and the average
number of cells per 10 microscopic ﬁelds was calculated. As
shown in Fig. 1D, mock infected cells (hatched bars) showed
substantial migration toward both MCP-1 and MCSF. In contrast,
PIV5-infected macrophages displayed signiﬁcantly reduced
migration toward these two chemokines. Taken together, these
results indicate that while WT PIV5 infection of macrophages
appears to have little overt effect on cell viability or cytokine
production, infected cells have a reduced capacity to migrate
toward chemoattractants.
MuV inhibits macrophage chemotaxis without altering cell surface
receptor expression
Based on the close relatedness of MuV and PIV5, we hypothe-
sized that MuV infection of primary human macrophages would
also result in restricted macrophage chemotaxis. As a ﬁrst step,
we determined if macrophages were susceptible to MuV infection
and the relative CPE caused by infection. Primary human macro-
phages were mock infected or infected with PIV5 as a positive
control or MuV at an moi of 10. At 24 h pi, cells were radiolabled
with 35S-labeled methionine and cysteine, and the P protein was
immunopreciptated from cell lysates using anti-P antibody and
SDS-PAGE. As shown in Fig. 2A, MuV-infected cells produced P
protein, similar to PIV5 infected cells. To conﬁrm that most cells
in the culture were susceptible to infection, macrophages were
infected at an moi of 10 with MuV and examined at 24 h pi by
immunoﬂuorescence with an antibody against the MuV NPMock
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Fig. 2. MuV-infected primary human macrophages maintain high viability. (A and B) Ex
infected with PIV5-GFP or MuV at an moi of 10. At 24 h pi, cells were radiolabe
immunoprecipitated from cell extracts with anti-P antibody before analysis by SDS-P
stained with antibody speciﬁc for the MuV NP protein (panel B). (C and D) Cell viability
an moi of 10 with MuV. At 24 h pi, cell viability was assayed using an MTT assay as des
indicating standard deviation) for samples from three individual donors. Alternative
(panel D).protein. As shown in Fig. 2B, the majority of the cells in the
population showed strong labeling for NP protein, which was not
seen in mock infected cells. However, similar to that seen with
PIV5, no progeny MuV was detected (data not shown). For
unknown reasons, many cells showed strong nuclear staining
for NP. This was not limited to NP, since nuclear staining was also
seen for both GFP (see Fig. 1A) and for P protein (not shown). The
role of nuclear accumulation of viral proteins is unknown.
Similar to the ﬁnding with PIV5, MuV infection did not result
in a large loss of macrophage viability. This is evident in the
viability assay for cells from three donors shown in Fig. 2C, where
the cell viability in MuV-infected cells was 100% of that seen
with mock infected cells. Similarly, analysis of MuV-infected
macrophages for apoptotic markers such as AnnexinV staining
showed no signiﬁcant difference compared to mock infected cells
(Fig. 2D). Taken together, these data indicate that primary human
macrophages are susceptible to infection with MuV, and that this
infection does not have a signiﬁcant impact on cell viability at
24 h pi.
To determine if MuV infection reduced the ability of macro-
phages to migrate toward chemoattractants, MDMs were mock
infected or infected with MuV at an moi of 10. At 24 h pi,
macrophages were analyzed for migration toward MCSF. As
shown in Fig. 3A, mock infected macrophages displayed low
levels of spontaneous migration toward the control PBS, but high
levels of migration toward MCSF. By contrast, macrophages
infected with MuV were blocked in migration toward MCSF.
Decreased migration by MuV-infected macrophages was inde-
pendent of which chemokine was used as an attractant (Fig. 3B).
Mock infected macrophages migrated toward MCSF, RANTES and
VEGF, while migration was inhibited toward all of these chemoat-
tractants in the case of MuV infected cells. As shown in Fig. 3C, the
MuV-induced inhibition of migration toward MCSF was depen-
dent on the moi, with minimal effect seen at an moi of 1, but
strong inhibition seen when cells were infected at mois of 5 and
25. Treatment of macrophages with UV-inactivated MuV virions
did not result in a signiﬁcant decrease in macrophage chemotaxis
(data not shown). It is noteworthy that the number of cells which90
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Fig. 3. MuV inhibits macrophage chemotaxis toward a range of chemokines. (A and B) Macrophages were mock infected or infected with MuV at an moi of 10. At 24 h pi, cells
were used in a migration assay with the indicated cytokines or PBS as a control as described in Materials and methods. Results are the mean number of cells counted in 10
high power ﬁelds (with bars indicating standard deviation) for three samples from a representative donor. ^po0.05; *po0.001. (C) Effect of MuV moi on chemotaxis.
Macrophages were mock infected or infected with MuV at the indicated moi. At 24 h pi, cells were used in a migration assay with MCSF or PBS as a negative control. Results
are the average number of cells counted in 10 high power ﬁelds (with bars indicating standard deviation) for three samples from a representative donor. *po0.001. (D)
Macrophages were mock infected or infected with MuV at an moi of 10. At 24 h pi, cells were stained with an antibody against CCR1 or CCR5 and percentage of positive
cells was analyzed by ﬂow cytometry.
C.M. Briggs et al. / Virology 433 (2012) 245–252248migrated toward a chemokine and the level of spontaneous
migration differed between individual cell preparations (e.g.,
compare the y axis in Fig. 3 panels), as would be expected when
assaying primary cells from a range of donors. However, in more
than 10 assays MuV infection always signiﬁcantly inhibited
migration compared to mock infected samples.
One possible explanation for decrease chemotaxis of MuV-
infected macrophages could be that chemokine receptors are down-
regulated. To test this hypothesis, primary human macrophages
were mock infected or infected with MuV at an moi of 10, and
MDMs were surface stained at 24 h pi with antibodies against either
CCR1 or CCR5, two known receptors for the chemokine RANTES but
not for MCSF or VEGF. As shown in Fig. 3D, no signiﬁcant decrease in
CCR1 or CCR5 expression was seen in MuV-infected macrophages
when compared to mock infected macrophages.
TNF-a produced from MuV-infected macrophages is necessary and
sufﬁcient to inhibit migration toward chemoattractants
As an alternative, we tested the hypothesis that a soluble
factor produced during MuV infection is responsible for the
inhibition of chemotaxis. Primary human macrophages were
mock infected or infected with MuV or PIV5 at an moi of 10. At
24 h pi, media from these cells was removed and treated with UV
light to inactivate any live virus. The UV-inactivated media was
added to naive uninfected macrophages overnight, and the
macrophages were then used in a migration assay toward MCSF.
As shown in Fig. 4A, cells treated with media from mock infectedcells were capable of migration toward MCSF. In contrast, UV-
inactivated media from either PIV5- or MuV-infected cells had a
signiﬁcant inhibiting effect on migration of uninfected macro-
phages. These data demonstrate that a soluble factor released
from virus-infected macrophages is capable of reducing chemo-
taxis in the absence of a live virus infection.
Macrophage inhibitory factor (MIF) is produced in response to
pathogens as a mechanism to retain macrophages at the site of
infection (Baugh and Bucala, 2002; Calandra and Rogers, 2003). To
determine if MIF was produced by MuV infected macrophages,
the amount of MIF released from infected cells was assayed by
ELISA. Since an moi of 25 was maximal at inhibition of migration
(see Fig. 3C), this moi was use in order to maximize differences in
cytokine induction. As shown in Fig. 4B, mock infected macro-
phages displayed low levels of MIF, which is consistent with
reports that low levels of MIF are constitutively produced by
some cells such as macrophages (Calandra and Rogers, 2003). The
positive control sample from A549 cells infected with the
cytokine-inducing PIV5 mutant P/V-CPI-, showed high levels of
MIF. Importantly, MuV-infected macrophages produce the same
levels of MIF as that seen with mock infected macrophages, a
ﬁnding that is inconsistent with an MIF-mediated inhibition of
macrophage migration.
TNF-a has been shown to inhibit chemotaxis (Grimshaw and
Balkwill, 2001; Herriott et al., 1993). To determine if TNF-a was
being produced by MuV-infected macrophages, media was col-
lected from infected MDMs and analyzed by an ELISA speciﬁc for
TNF-a. As shown in Fig. 4C for three experiments with three
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C.M. Briggs et al. / Virology 433 (2012) 245–252 249different donors, MuV-infected macrophages had elevated levels
of TNF-a compared to mock infected macrophages.
To test the role of TNF-a in MuV-mediated inhibition of
chemotaxis, MDMs were mock infected or infected with MuV at
an moi of 10. An excess of a neutralizing antibody against TNF-a, or
IFN-b as a control, was added to media immediately after infection,
and cell migration was assayed as described above. As shown in
Fig. 5A, MuV infected macrophages had signiﬁcantly reduced
migration toward MCSF, but this inhibition was relieved in samples
treated with the anti-TNF neutralizing antibody. It is noteworthy
that the neutralizing anti-TNF-a antibody also enhanced the migra-
tion of mock infected cells (hatched bars, Fig. 5A). This is consistent
with the ﬁnding of low levels of TNF-a that are released constitu-
tively from macrophages from individual donors (see Fig. 4C). This
enhancing effect of neutralizing antibody on cell migration was not
seen with a control IFN-b antibody (Fig. 5B). MuV-infected macro-
phages treated the neutralizing antibody against IFN-b displayed a
reduced level of migration, similar to that seen in non-treated,
infected macrophages.
To determine if TNF-a alone was sufﬁcient to inhibit macro-
phage chemotaxis, primary human macrophages were treated
overnight with exogenous TNF-a, at levels similar to the amountof TNF-a produced during MuV infection seen in Fig. 4C. Treated
macrophages were used in a migration assay as described above
but without prior MuV infection. As shown in Fig. 6, uninfected
macrophages treated with PBS as a control were able to migrate
toward MCSF. Most importantly, uninfected macrophages treated
with exogenous TNF-a were deﬁcient in their ability to migrate
toward MCSF. Together, these data demonstrate that TNF-a is
both necessary (Fig. 5A) and sufﬁcient (Fig. 6) for MuV-mediated
inhibition of macrophage chemotaxis.Discussion
Macrophages are important cells of both innate and adaptive
immunity that play a crucial role in controlling viral infection. Our
results indicate that primary human macrophages are susceptible
to infection with both PIV5 and MuV, and that these infections do
not appear to induce overt CPE. We have shown that macro-
phages infected with either PIV5 or MuV are inhibited from
migration toward a range of chemoattractants. For MuV, this
inhibition is caused by a soluble factor secreted during MuV
infection. Our most striking ﬁnding came from our work
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Fig. 6. TNF-a is sufﬁcient for inhibition of macrophage migration. Macrophages were
treated for 24 h with PBS or 120 pg/ml exogenous TNF-a before being used in a
migration assay with MCSF or PBS as a negative control. Results are the average
number of cells counted in 10 high power ﬁelds (with bars indicating standard
deviation) for three samples from a representative donor. Data are representative
of the results obtained from multiple experiments with cells from different
donors. ***po0.001.
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macrophages is both necessary and sufﬁcient to inhibit macro-
phage migration. As detailed below, these data suggest a model
whereby production of TNF-a during MuV infection acts in an
autocrine and paracrine fashion to inhibit migration of naı¨ve and
infected macrophages alike.
We have previously shown that WT PIV5 induces massive CPE
and apoptosis in primary human monocyte-derived dendritic
cells (Arimilli et al., 2006). This contrasts with the ﬁndings here
that WT PIV5 infection of MDMs resulted in a productive infection
with no evidence of overt CPE or apoptosis. Thus, PIV5 infected
macrophages show properties similar to that of infected epithelial
or ﬁbroblast cells: low CPE and poor induction of cytokines such
as IL-6 and IFN-beta (He et al., 2002; Wansley and Parks, 2002).
The mechanism for these widely differing outcomes of PIV5
infection of dendritic cells and macrophages is currently under
investigation. Most importantly for this study, PIV5 infection of
MDMs did not induce substantial levels of MIF-1 or TNF-a,
consistent with the low induction of all cytokines by this virus.
Thus, while PIV5 infection inhibited macrophage migration, it
appears to be through a different mechanism from that of MuV.
MuV infected macrophages were strongly inhibited in chemo-
taxis toward a range of chemokines which utilize different receptors
to induce migration. For example, the receptor which detects MCSF
and VEGF is a homodimeric type III receptor tyrosine kinase
(Hamilton, 2008; Holmes and Zachary, 2007), whereas RANTES
and MCP-1 are detected by G-protein coupled receptors (GPCRs)
(Neote et al., 1993; Monteclaro and Charo, 1996). These ﬁndings
raise the hypothesis that MuV infection might induce a global
reduction in levels of cell surface receptors. Flow cytometric analysis
indicated that MuV infection did not alter levels of MDM cell surface
CCR1 and CCR5. Thus, while we cannot eliminate the possibility of
changes at later times pi, our results do not support a model
whereby the inhibition of migration is due to altered cell surface
receptor expression. In addition, analysis of the macrophage actin
cytoskeleton using phalloidin showed no obvious differences in
morphology of mock infected versus MuV infected macrophages
(data not shown). Thus, the inhibition of migration appears to occur
after receptor–ligand binding, but before changes in the macrophage
cytoskeleton have occurred.
Our data indicate that a soluble factor produced during MuV
infection is responsible for inhibiting the migration of macrophages,consistent with previous results from the 1970s which showed that
MuV infection leads to the secretion of migration-inhibitory factors.
Parotid gland ﬂuid recovered from chimpanzees with clinical signs
of MuV infection was found to decrease macrophage migration
toward chemoattractants (Flanagan et al., 1973; Yoshida et al.,
1974). Due to the discovery of the chemokine MIF, the ﬂuid was
described as having ‘‘MIF-like’’ activity, although the identity of the
secreted factor was never determined. Our results indicate that the
inhibitory factor secreted from MuV-infected macrophages is not
MIF, as MuV infection did not elicit levels of MIF above those
produced by mock infected cells. This result differs from those
obtained using human cytomegalovirus (HCMV) (Frascaroli et al.,
2009), where elevated levels of MIF produced during viral infection
were shown to be responsible for the loss of chemotaxis (Frascaroli
et al., 2009).
Why is MIF induced by HCMV infection but not by MuV? The
double stranded DNA virus HCMV is most likely detected by
different host cell receptors compared to the negative strand RNA
virus MuV. While cells such as macrophages have been shown to
express MIF constitutively, MIF is signiﬁcantly upregulated fol-
lowing TLR stimulation (Calandra and Rogers, 2003). MIF is
induced through TLR2 and TLR4 but not through TLR3/7 (Popa
et al., 2006), and HCMV is capable of signaling through TLR2
(Compton et al., 2003). Conversely, Rubulaviruses such as PIV5
are detected by cytoplasmic RIG-I, and not MDA-5 or TLR3 in
epithelial cells (Manuse and Parks, 2009). As macrophages
express cytoplasmic sensors such as RIG-I (Manuse and Parks,
2009), we hypothesize that differential activation of pathogen
sensing pathways results in the induction of MIF by HCMV but
not by MuV. Why is PIV5 a much poorer inducer of TNF-alpha
compared to MuV? While it is clear that multiple strain differ-
ences (both in PIV5 and MuV) can account for differential
cytokine induction (e.g., Young and Parks, 2003), we have recently
shown that the paramyxovirus polymerase components are an
important factor in modulating host cell responses (Dillon and
Parks, 2007). Thus, we hypothesize that PIV5 replication produces
fewer inducers of host responses compared to MuV replication,
and thus induces lower levels of TNF-alpha and other proinﬂam-
matory cytokines.
Our most striking result was the contribution of TNF-a to the
inhibition of macrophage migration. MuV was shown to be a
strong inducer of TNF-a from infected macrophages, and secreted
TNF-awas necessary for MuV-mediated inhibition of macrophage
migration. Importantly, the inhibition of migration could be
reproduced by treatment of uninfected macrophages with TNF-
a, indicating that TNF-a was also sufﬁcient for inhibitor effects.
This is consistent with prior studies demonstrating that treatment
of naı¨ve macrophages with TNF-a is sufﬁcient to inhibit migration
(Grimshaw and Balkwill, 2001; Herriott et al., 1993). TNF-a can
clearly play important roles in promoting innate and adaptive
immunity, but can also be problematic when expression is
deregulated. In our model, MuV takes advantage of the induction
of TNF-a during replication to prevent macrophage migration and
thus, limit the pro-immune functions of macrophages in antiviral
responses. The migration of many cell types requires signaling
through the mitogen-activated protein kinase (MAPK) pathways,
which act through a phosphorylation cascade (Pearson et al.,
2001). Whereas increased levels of MAPK phosphorylation is seen
in macrophages exposed to the chemoattractant MCP-1
(Grimshaw and Balkwill, 2001), exposure to TNF-a induced
increased levels of MAPK phosphatase 1 (MKP-1) (Grimshaw
and Balkwill, 2001). MKP-1 has been shown to be a negative
regulator of MAPK signaling, functioning by de-phosphorylating
MAPK (Chi et al., 2006; Salojin et al., 2006). We hypothesize that
secretion of TNF-a by MuV-infected macrophages is able to signal
on cells in an autocrine or paracrine fashion, and upregulate the
C.M. Briggs et al. / Virology 433 (2012) 245–252 251production of MKP-1. Future work will delineate the effect of
MuV on MAPK signaling pathways, including the role of MKP-1 in
macrophage migration.Materials and methods
Cells, viruses and bacteria
Immature peripheral blood mononuclear cells (PBMCs) were
derived from whole human blood as described previously
(Arimilli et al., 2006; Briggs et al. 2011). Brieﬂy, PBMCs were
isolated from randomly selected donors by standard density
gradient centrifugation on Ficoll-Hypaque. CD14þ monocytes
were isolated by positive selection using CD14þ microbeads
(Miltenyi-Biotec). Generally, the isolated cells were found to be
Z95% CD14þ as assayed by ﬂow cytometry. The resulting
CD14þ monocytes were cultured for 6 d in RPMI media (Lonza)
containing 10 ng/mL macrophage colony stimulating factor
(MCSF) supplemented with 10% FBS, and 1% each of L-glutamine,
penicillian/streptomycin, NEAA, 1 M HEPES, and sodium pyruvate
(Lonza). After 3 d in culture, half of the media was replaced, and
additional MCSF was added at the concentrations listed above. At
day 6, Z90% of cells were CD64þ and CD14þ (data not shown).
Data are representative of the results obtained from multiple
experiments with individual cells from different donors. Donor
cells were not pooled for experiments. WT PIV5-GFP and the P/V-
CPI-mutant have been described previously (Wansley and Parks,
2002). MuV (Enders Strain, ATTC VR-1379) was grown in CV-1
cells as described (Johnson et al., 2008).
Isotopic labeling and immunoprecipitation
In radiolabel experiments, macrophages were mock infected or
infected at a high moi with virus as indicated in ﬁgure legends. At
the time pi indicated in ﬁgure legends, cells were starved for
25 min with DMEM lacking cysteine and methionine and then
radiolabeled for 2 h with 100 mCi/ml Tran[35S]-label. Equal
amounts of protein were immunoprecipitated using rabbit poly-
clonal antisera to PIV5 P proteins as described previously (Dillon
et al., 2006), before SDS-PAGE and autoradiography.
Macrophage migration assays
Human recombinant MCSF, regulated upon activation, Normal
T cell expressed and secreted (RANTES/CCL5), vascular endothe-
lial growth factor (VEGF), or monocyte chemotactic protein-1
(MCP-1/CCL2) were from Invitrogen and were each used at the
ﬁnal concentration of 100 ng/ml in migration media (RPMI 1640
supplemented with 1% FBS). Macrophages were removed from
culture dishes using Accutase (Millipore, Inc), pelleted and resus-
pended in migration media. Cells were seeded at a density of
2105 cells/well on one side of the culture dish. Chemotaxis was
evaluated using 24-well Boyden chambers (BD Biosciences) con-
taining a 3-mm pore polycarbonate ﬁlters as previously described
(Frascaroli et al., 2009). Cells were allowed to migrate across the
ﬁlter for 5 h at 37 1C in a tissue culture incubator. Filters were
then removed, ﬁxed and stained using Diff QUICK Stain kit (IMEB
Inc.). Using a microscope, the number of cells that had migrated
to the opposing side of the ﬁlter was calculated as the number of
cells counted in 10 consecutive high power ﬁelds. All stimuli were
assayed in triplicate, and results were expressed as mean number
of cells7SD. To determine the effect of TNF-a on migration, a
neutralizing antibody against TNF-a (Biosource Inc.) or IFN-b (PBL
International) was added to cells immediately following infectionat a concentration of 10 mg/mL. Exogenous TNF-a (Promega) was
added to naı¨ve macrophages at a concentration of 100 pg/mL.
ELISA and cell viability assays
Immunoreactive IL-6, TNF-a (BD Opt EIA; BD Biosciences), or
MIF (Ray Biotech) was quantiﬁed by ELISA according to manufac-
turer’s protocols, and levels were normalized to 106 cells. Cell
viability was measured at the indicated times pi by using a
CellTiter 96 AQueaous One Solution cell proliferation assay
(Promega) according to the manufacturer’s instructions. Data
were from quadruplicate samples and are expressed as fold
increase in cell viability relative to mock infected cells.
FACS, immunoﬂuorescence and microscopy
For detection of surface markers, cells were stained with
antibodies speciﬁc for the CCR1 and CCR5 receptors according
to manufacturer’s recommendations (BD Pharmigen). Samples
were analyzed on a FACScan Caliber instrument using Cell Quest
software (Becton-Dickinson).
In immunoﬂuorescence experiments, cells were infected at
high moi and at 24 h pi were ﬁxed at 4 1C in ice-cold 100%
methanol. After washing, cells were incubated with a primary
antibody against the MuV NP protein (gift of Tony Schmidt, Penn
State University), and a secondary antibody conjugated to a 488
ﬂuorophore (Alexaﬂuor). Phase and ﬂuorescent microscopy were
carried out as described previously using a Nikon Eclipse micro-
scope and a 20x lens (Wansley and Parks, 2002). Images were
captured under phase contrast or visualized for GFP or DAPI
expression using Qimaging digital camera and processed using Q-
capture software. Exposure times were manually set to be con-
stant among samples.Acknowledgments
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